Trial
NCT02435836
A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborators
—
Condition
Schizophrenia
Intervention
Aripiprazole
Why stopped
Study terminated when aripiprazole available commercially per protocol
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-09-21